2nd Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for AVANIR PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA Labeling of pharmaceutical, general pharmaceutical issues.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
MONICA MASSARO —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General Medicare coverage of pharmaceutical drugs and Medicare quality programs. Medicare specialty tier cap increase.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
MONICA MASSARO —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.